Paces Ferry Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Sell
2,881
-146
-5% -$21.9K 0.17% 78
2026
Q1
$462K Sell
3,027
-1
-0% -$153 0.19% 68
2025
Q4
$417K Sell
3,028
-56
-2% -$7.33K 0.17% 79
2025
Q3
$395K Hold
3,084
0.16% 74
2025
Q2
$373K Sell
3,084
-155
-5% -$17.5K 0.17% 74
2025
Q1
$361K Sell
3,239
-186
-5% -$19.8K 0.18% 78
2024
Q4
$333K Sell
3,425
-155
-4% -$16.5K 0.16% 83
2024
Q3
$412K Sell
3,580
-17
-0.5% -$1.93K 0.24% 69
2024
Q2
$383K Sell
3,597
-88
-2% -$8.83K 0.23% 74
2024
Q1
$356K Sell
3,685
-262
-7% -$26.9K 0.23% 75
2023
Q4
$399K Sell
3,947
-12
-0.3% -$1.16K 0.28% 69
2023
Q3
$403K Sell
3,959
-147
-4% -$14.9K 0.32% 63
2023
Q2
$414K Sell
4,106
-142
-3% -$14.2K 0.31% 62
2023
Q1
$391K Sell
4,248
-1,755
-29% -$153K 0.32% 67
2022
Q4
$545K Sell
6,003
-773
-11% -$65.1K 0.53% 39
2022
Q3
$515K Sell
6,776
-2
-0% -$166 0.56% 40
2022
Q2
$573K Sell
6,778
-646
-9% -$56.7K 0.56% 41
2022
Q1
$651K Buy
7,424
+1,739
+31% +$151K 0.52% 43
2021
Q4
$497K Sell
5,685
-2,229
-28% -$185K 0.36% 58
2021
Q3
$647K Sell
7,914
-497
-6% -$44.7K 0.52% 43
2021
Q2
$767K Buy
8,411
+41
+0.5% +$3.65K 0.59% 45
2021
Q1
$715K Buy
8,370
+597
+8% +$53.6K 0.62% 44
2020
Q4
$734K Buy
7,773
+2,144
+38% +$187K 0.67% 41
2020
Q3
$489K Buy
+5,629
New +$488K 0.43% 51

Other funds holding NVS

Paces Ferry Wealth Advisors's NVS Position: Q2 2026 in Review

Paces Ferry Wealth Advisors reduced its Novartis (NVS) stake by 4.8% in Q2 2026, selling an estimated $21.9K and leaving 2,881 shares worth $452K. The position accounts for 0.17% of the portfolio, ranked #78.

Paces Ferry Wealth Advisors first reported a position in NVS in Q3 2020 and has held it in 24 quarters since. The position peaked at $767K in Q2 2021. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Paces Ferry Wealth Advisors held 2,881 shares of Novartis worth $452K as of Q2 2026.
  • Paces Ferry Wealth Advisors sold 146 Novartis shares in Q2 2026, an estimated $21.9K.
  • Novartis made up 0.17% of Paces Ferry Wealth Advisors's portfolio in Q2 2026, its #78 holding.
  • Paces Ferry Wealth Advisors first reported a position in Novartis in Q3 2020 and has held it in 24 quarters since.
  • Paces Ferry Wealth Advisors's Novartis position peaked at $767K in Q2 2021.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Paces Ferry Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.